The present invention concerns compounds of formula (A1)(A2)N—R1 (I),the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary amines and stereochemically isomeric forms thereof, wherein R1 is substituted C1-6alkyl; —S(O)—R8; —S(O)2—R8; C7-12alkylcarbonyl; optionally substituted C1-6alkyloxycarbonylC1-6alkylcarbonyl; with R8 being C1-6alkyl, aryl1 or Het1; (A1)(A2)N— is the covalently bonded form of the corresponding intermediate of formula (A1)(A2)N—H, which is a HIV replication inhibiting pyrimidine of formula ##STR1##

 
Web www.patentalert.com

< Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus

< Use of lipid conjugates in the treatment of disease

> Pyrrolo[1,2-B]pyridazine compounds and their uses

> Pyralopyridines, process for their preparation and use as therapeutic compounds

~ 00256